Trial Details
COMPLETEDBasic Information
| Clinical ID | c4586 |
|---|---|
| Identifier | NCT00291668 |
| Trial Title | Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab Pegol|OTHER: Placebo |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Aichi-ken |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-03-02 |
|---|---|
| Primary Completion Date | 2007-11-08 |
| Completion Date | 2007-11-08 |